Current Environment: Production

Mia Chandler | Education

Undergraduate School

University of South Carolina

Columbia, SC

Graduate School

Harvard T.H. Chan School of Public Health

Boston, MA

Medical School

Medical University of South Carolina

Charleston, SC

Internship

Baystate Medical Center, UMASS Medical School

Springfield, MA

Residency

Pediatrics

Baystate Medical Center, UMASS Medical School

Springfield, MA

Fellowship

Rheumatology

Boston Children's Hospital

Boston, MA

Mia Chandler | Certifications

  • American Board of Pediatrics (General)

Mia Chandler | Publications

  1. Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2025 Mar 17. View Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis. Abstract

  2. Universal health-related social needs screening in a paediatric rheumatology clinic. Rheumatol Adv Pract. 2025; 9(2):rkaf014. View Universal health-related social needs screening in a paediatric rheumatology clinic. Abstract

  3. Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions. BMJ Open. 2024 08 24; 14(8):e087918. View Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions. Abstract

  4. Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease. J Rheumatol. 2024 Aug 01; 51(8):811-817. View Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease. Abstract

  5. Classifying Individuals With Rheumatic Conditions as Financially Insecure Using Electronic Health Record Data and Natural Language Processing: Algorithm Derivation and Validation. ACR Open Rheumatol. 2024 Aug; 6(8):481-488. View Classifying Individuals With Rheumatic Conditions as Financially Insecure Using Electronic Health Record Data and Natural Language Processing: Algorithm Derivation and Validation. Abstract

  6. Racial and Ethnic Composition of Populations Served by Freestanding Children's Hospitals and Disparities in Outcomes of Pediatric Lupus. Arthritis Care Res (Hoboken). 2024 07; 76(7):926-935. View Racial and Ethnic Composition of Populations Served by Freestanding Children's Hospitals and Disparities in Outcomes of Pediatric Lupus. Abstract

  7. A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole. Vaccine. 2024 Apr 02; 42(9):2127-2134. View A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole. Abstract

  8. Social Determinants of Health Documentation Among Individuals With Rheumatic and Musculoskeletal Conditions in an Integrated Care Management Program. Arthritis Care Res (Hoboken). 2023 12; 75(12):2529-2536. View Social Determinants of Health Documentation Among Individuals With Rheumatic and Musculoskeletal Conditions in an Integrated Care Management Program. Abstract

  9. Understanding Stakeholders' Perspectives to Increase COVID-19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions. Arthritis Care Res (Hoboken). 2023 12; 75(12):2508-2518. View Understanding Stakeholders' Perspectives to Increase COVID-19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions. Abstract

  10. Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2023 10; 75(10):2063-2072. View Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. Abstract

  11. Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. Front Immunol. 2022; 13:1068399. View Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. Abstract

  12. Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus. Semin Arthritis Rheum. 2023 02; 58:152122. View Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus. Abstract

  13. Recognizing Racial Bias and Promoting Diversity in the Rheumatology Workforce. Arthritis Rheumatol. 2022 09; 74(9):1459-1463. View Recognizing Racial Bias and Promoting Diversity in the Rheumatology Workforce. Abstract

  14. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. J Rheumatol. 2022 Sep; 49(9):1042-1051. View An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. Abstract

  15. Pediatric EVALI in the Age of COVID-19/MIS-C: Diagnostic Considerations. Hosp Pediatr. 2022 07 01; 12(7):e249-e254. View Pediatric EVALI in the Age of COVID-19/MIS-C: Diagnostic Considerations. Abstract

BESbswy